Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David L. Musso"'
Autor:
Hiral A Bhagat, Sarah A Compton, David L Musso, Christopher P Laudeman, Kimberly M P Jackson, Na Young Yi, Lidia S Nierobisz, Lawrence Forsberg, Jay E Brenman, Jonathan Z Sexton
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204605 (2018)
Obesity and insulin resistance are primary risk factors for Non-Alcoholic Fatty Liver Disease (NAFLD). NAFLD is generally exhibited by non-progressive simple steatosis. However, a significant subset of patient's progress to nonalcoholic steatohepatit
Externí odkaz:
https://doaj.org/article/6351b1f11d1e45c7bf7374679a1fea1a
Autor:
David L. Musso, et al. et al.
Publikováno v:
ChemInform. 32
Autor:
Millard H, Lambert, R Kevin, Blackburn, Theresa D, Seaton, Daniel B, Kassel, Daniel S, Kinder, M Anthony, Leesnitzer, D Mark, Bickett, Janet R, Warner, Marc W, Andersen, Jennifer G, Badiang, David J, Cowan, Michael D, Gaul, Kimberly G, Petrov, Michael H, Rabinowitz, Robert W, Wiethe, J David, Becherer, Darryl L, McDougald, David L, Musso, Robert C, Andrews, Marcia L, Moss
Publikováno v:
Combinatorial chemistryhigh throughput screening. 8(4)
We report a systematic analysis of the P1' and P2' substrate specificity of TNF-alpha converting enzyme (TACE) using a peptide library and a novel analytical method, and we use the substrate specificity information to design novel reverse hydroxamate
Publikováno v:
Organicbiomolecular chemistry. 1(3)
The synthesis of a novel series of 3-phenylprop-2-ynylamines as selective mammalian squalene epoxidase inhibitors is described. Structure activity relationship studies led to the discovery of compound 19, 1-[3-(3,5-dichlorophenyl)-prop-2-ynyl]-3- met
Autor:
David L. Musso
Publikováno v:
Current Topics in Medicinal Chemistry. 3:ii-ii